Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson’s disease? Neural Regeneration Research . 2015, (10): 1578 -1580 .  DOI: 10.4103/1673-5374.165228